Molecular Devices Leads Strong Week for BCW Index | GenomeWeb
Shares of Molecular Devices rose 7.1 percent for the five-day trading period ended Tuesday, leading all firms in the BCW Index. All 15 companies in the Index gained ground for the week, though Bruker was the only other firm to eclipse a 5-percent rise for the period.
 
Overall, the Index rose 2.4 percent. In comparison, the Dow Jones Industrial Average and the Nasdaq each gained 1.6 percent for the same period. The Nasdaq Biotech Index was up 1.8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.